Conference Coverage
Conference Coverage
Unresolved fatigue lingers for most PsA patients
MADRID – Three factors appear most responsible for the majority of reported patient fatigue.
Conference Coverage
Children with psoriasis face multitude of comorbidities
CHICAGO – Obesity ranks as the most well-understood comorbidity of psoriasis in children. Furthermore, many obese children with psoriasis may also...
Conference Coverage
Ixekizumab helps PsA patients who failed a TNFi
MADRID – Ixekizumab appears to be a good second-line choice for TNFi-unresponsive patients.
Conference Coverage
Comorbidities in psoriatic arthritis flag worse prognosis
MADRID - Focus on comorbidities to improve treatment.
Conference Coverage
Early phase III data positive for adalimumab biosimilar, for both psoriasis and PsA
Response curves were nearly identical for adalimumab and the biosimilar
Conference Coverage
Pain often persists despite biologic treatment in PsA
MADRID – Psoriatic arthritis patients may have more than just inflammatory pain symptoms.
Conference Coverage
Infliximab biosimilar noninferior to originator in IBD – NOR-SWITCH
CHICAGO – Can use of biosimilars save money for IBD patients and health care systems?
Conference Coverage
Some data support botulinum toxin for psoriasis and rosacea
ORLANDO – Can psoriasis and rosacea symptoms be significantly improved with neuromodulator treatment?
Conference Coverage
Pediatric psoriasis may have a distinct presentation
Psoriasis may present differently in children.
Conference Coverage
How to get the most out of methotrexate for psoriasis
WAILEA, HAWAII – Methotrexate is the most cost-effective way to manage extensive psoriasis.